Merck & Co.'s proposed settlement with insurers over a $1.4 billion claim related to the NotPetya attack will change the language the insurance industry uses to exclude acts of war in its policies, and organizations need to consider how those changes affect risk, said attorney Peter Halprin.

How the Merck Case Shapes the Future of Cyber Insurance

Exclusive, insightful audio interviews by our staff with healthcare/security leading practitioners and thought-leaders.  Transcripts are also available on our site!

Technology

Tech News

Podcasting

Gadgets

Software How-To

Health

Alternative Health

Self-Help

Sexuality

Fitness & Nutrition

Information Security Media group CTO and CISO Dan Grosu discusses the challenges of realistically implementing the directives in President Joe Biden's executive order on artificial intelligence. Hint: He thinks it's going to be "a madhouse" if enterprises don't get more educated about AI.

Regulating AI: 'It's Going to Be a Madhouse'

While fewer healthcare websites appear to be using online trackers now than a year ago, nearly 1 in 3 firms are still using Meta Pixel and similar tech tools despite warnings from regulators and a rise in class action litigation alleging privacy violations, said Ian Cohen, CEO of Lokker.

Web Trackers Persist in Healthcare Despite Privacy Risks

SecurityGate CEO Ted Gutierrez said the SEC's new cybersecurity mandates give "more teeth to the idea that cybersecurity is a business problem." He discussed the need for CISOs to link cyber risk and business outcomes and other ways in which the rules affect the field of cybersecurity.

Correlating Cyber Investments With Business Outcomes

While most healthcare sector organizations hit with ransomware attacks never imagine giving in to extortion demands, the pressures they face in dealing with the crisis often push about half of them to pay, said attorney Lynn Sessions of BakerHostetler, speaking about the firm's healthcare clients.

Why Many Healthcare Sector Entities End Up Paying Ransoms

Medical device makers submitting products for premarket approval by the Food and Drug Administration often struggle the most with cybersecurity in three major areas - design controls, providing a software bill of materials and testing, according to Nastassia Tamari of the FDA.

How the Merck Case Shapes the Future of Cyber Insurance

Download our free app to listen on your phone